|ELANCO R&D||Advisor External Innovation||Switzerland|
HOW CAN COMMON PATHWAYS IN HUMAN AND ANIMAL HEALTH SET UP A NEW ERA FOR COLLABORATIONS?
Steve Nanchen has been working in the Animal Health Industry for more than 10 years. Steve holds a PhD in organic chemistry from the University of Basel, Switzerland. After a postdoctoral stay at Stanford University in the US, Steve started his industrial career as a medicinal chemist at Novartis Animal Health. Since then, he has held various positions in R&D, leading global projects from early discovery to development and regulatory submissions. Steve is now working in the External Innovation group of Elanco Animal Health. There, Steve first worked on leveraging R&D assets from Lilly. He is now responsible for the identification and evaluation of new and innovative animal health solutions for Elanco Animal Health in collaboration with biotech companies and academic groups.